Antipsychotics Fall Short in Delirium
The Carlat Psychiatry Report, Volume 18, Number 4, April 2020
https://www.thecarlatreport.com/newsletter-issue/tcprv18n4/
Issue Links: Learning Objectives | Editorial Information
Topics: Dopamine | Geriatric Psychiatry | Neurology | Novel Medications | Nuplazid | Parkinson’s
Adrienne Grzenda, MD.
Dr. Grzenda has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Antipsychotics remain a mainstay of delirium treatment despite significant concerns about their safety and efficacy. A pair of reports recently evaluated the evidence on their use in delirium.
You can't view details of this content, please login or buy subscription here